FACT subunit SUPT16H associates with BRD4 and contributes to silencing of interferon signaling

Nucleic Acids Res. 2022 Aug 26;50(15):8700-8718. doi: 10.1093/nar/gkac645.

Abstract

FACT (FAcilitates Chromatin Transcription) is a heterodimeric protein complex composed of SUPT16H and SSRP1, and a histone chaperone participating in chromatin remodeling during gene transcription. FACT complex is profoundly regulated, and contributes to both gene activation and suppression. Here we reported that SUPT16H, a subunit of FACT, is acetylated in both epithelial and natural killer (NK) cells. The histone acetyltransferase TIP60 contributes to the acetylation of SUPT16H middle domain (MD) at lysine 674 (K674). Such acetylation of SUPT16H is recognized by bromodomain protein BRD4, which promotes protein stability of SUPT16H in both epithelial and NK cells. We further demonstrated that SUPT16H-BRD4 associates with histone modification enzymes (HDAC1, EZH2), and further regulates their activation status and/or promoter association as well as affects the relevant histone marks (H3ac, H3K9me3 and H3K27me3). BRD4 is known to profoundly regulate interferon (IFN) signaling, while such function of SUPT16H has never been explored. Surprisingly, our results revealed that SUPT16H genetic knockdown via RNAi or pharmacological inhibition by using its inhibitor, curaxin 137 (CBL0137), results in the induction of IFNs and interferon-stimulated genes (ISGs). Through this mechanism, depletion or inhibition of SUPT16H is shown to efficiently inhibit infection of multiple viruses, including Zika, influenza, and SARS-CoV-2. Furthermore, we demonstrated that depletion or inhibition of SUPT16H also causes the remarkable activation of IFN signaling in NK cells, which promotes the NK-mediated killing of virus-infected cells in a co-culture system using human primary NK cells. Overall, our studies unraveled the previously un-appreciated role of FACT complex in coordinating with BRD4 and regulating IFN signaling in both epithelial and NK cells, and also proposed the novel application of the FACT inhibitor CBL0137 to treat viral infections.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • COVID-19
  • Cell Cycle Proteins / metabolism*
  • DNA-Binding Proteins / genetics
  • Epithelial Cells / immunology
  • Epithelial Cells / metabolism*
  • High Mobility Group Proteins / genetics
  • Humans
  • Interferons / metabolism*
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / metabolism*
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism
  • SARS-CoV-2
  • Signal Transduction*
  • Transcription Factors / metabolism*
  • Transcriptional Elongation Factors / genetics
  • Zika Virus / metabolism
  • Zika Virus Infection

Substances

  • BRD4 protein, human
  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • High Mobility Group Proteins
  • Nuclear Proteins
  • SSRP1 protein, human
  • SUPT16H protein, human
  • Transcription Factors
  • Transcriptional Elongation Factors
  • Interferons